课题基金 / 基金详情

A novel mouse model of testicular granulosa cell tumors

A novel mouse model of testicular granulosa cell tumors
一种新型小鼠睾丸颗粒细胞瘤模型
批准号:
10062490
负责人:
Qinglei Li
金额:
$7.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-12-01 至 2022-11-30

项目摘要

项目成果

Qinglei Li的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Title: A novel mouse model of testicular granulosa cell tumors PROJECT SUMMARY Despite the relatively high 5-year survival rate of granulosa cell tumors (GCTs) in stage I patients, poor prognosis is associated with patients at advanced tumor stage, justifying the need to study this type of poorly defined tumors. Of note, GCTs may also arise from the testis with low incidence. Thus, animal models are useful to investigate the pathogenesis of this disease. Overactivation of transforming growth factor β (TGFβ) receptor 1 (TGFBR1) using Amhr2-Cre to target mouse granulosa cells provokes the development of ovarian GCTs. It was found that male mice develop testicular GCTs at an early age. The exciting phenotypic manifestation of GCTs in the testes of these mice raised the question of how dysregulated TGFβ signaling promotes testicular GCT formation. The central hypothesis is that dysregulation of TGFβ signaling alters the differentiation program of Sertoli cells, promoting the transdifferentiation of Sertoli cell to malignant granulosa cells characteristic of GCTs. This hypothesis is based on compelling genetic evidence, and will be tested in a single aim by identifying mechanistic underpinnings of testicular GCT development resulting from constitutive activation of TGFBR1. A comprehensive approach combining transcriptomic and proteomic analyses will be utilized to address the posed question. Results of this application are expected to provide a paradigm shift for understanding gonadal tumorigenesis and reveal a novel link among growth factor signaling, cell fate alteration, and oncogenesis. Therefore, completion of this proposal will have a significant impact on the etiology of testicular GCTs. The findings have potential diagnostic and therapeutic value for sex cord-stromal tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UTX: A novel regulator of decidualization?
  • 批准号:
    10390537
  • 项目类别:
  • 资助金额:
    $7.3万
  • 财政年份:
    2022
  • 负责人:
    Qinglei Li
  • 依托单位:
UTX: A novel regulator of decidualization?
  • 批准号:
    10570990
  • 项目类别:
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Qinglei Li
  • 依托单位:
TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION
  • 批准号:
    9886078
  • 项目类别:
  • 资助金额:
    $30.44万
  • 财政年份:
    2017
  • 负责人:
    Qinglei Li
  • 依托单位:
TGF-BETA SIGNALING IN ENDOMETRIAL CELL FUNCTION AND DYSFUNCTION
  • 批准号:
    10112273
  • 项目类别:
  • 资助金额:
    $29.77万
  • 财政年份:
    2017
  • 负责人:
    Qinglei Li
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: